Pregnancy Clinical Trial
Official title:
Intergenerational Strengths-Based Program for American Indian Girls as They Transition to Adulthood
The investigators will conduct a pilot study to assess the acceptability, feasibility,
satisfaction, and participant-level outcomes among girls and their mother/female caregiver
participating in a preconception health program. The program was developed through an
extensive formative phase and is delivered weekly over ~3 months. The investigators will
enroll a total of 60 female caregivers and their 8-11 year old daughters/female children to
participate in the program and evaluation. Implementation data including acceptability,
feasibility and satisfaction will be collected through REDCap and paper assessments completed
after each program session and at the completion of the program. Preliminary impact data will
be collected through REDCap up to 3 months post-intervention completion.
The aims are as follows:
1. To understand if the preconception health program is feasible and acceptable among young
girls and their mothers or female caregivers
2. To explore optimal implementation of the program to inform future research and scale up.
3. To assess preliminary impact of the preconception health program on girls' and
caregiver's knowledge, cultural connectedness, caregiver-child relationship, community
and school connectedness, coping skills, parenting self-efficacy, depression, quality of
life as well as substance use behaviors and intentions and intention about sexual
activity.
The investigators will conduct a pilot evaluation to understand the feasibility,
acceptability, satisfaction and explore preliminary impacts of a preconception health
program. The primary research question is: Is the preconception health program developed
through the formative phase of this study acceptable and feasible to girls and caregiver
participants? The program aims to improve the overall health and wellbeing of girls and their
female caregivers by decreasing and delaying the initiation of substance use and risk
behaviors associated with sexual initiation among adolescent girls. A second research
question is: does the preconception health program have preliminary impacts on key protective
and risk factors related to substance use and risky sexual behavior among girls and their
female caregivers?
The Preconception Health Program will consist of 11 sessions conducted with girls ages 8-11
and their female caregivers. 5 of the 11 sessions will be taught to groups of 8-12 girls and
their mothers, and 6 of the sessions will be taught to individual girl/female caregivers'
dyads. The mix of group- and home-based lessons is based on findings from the formative phase
about preference for certain topics to be taught in groups vs. individual dyads. Each of the
sessions (group and individual) will be 60-90 minutes in duration and delivered by a trained
Family Health Coach (FHC). Group sessions will take place at a local community center in a
private room. Individual dyad sessions will take place in the girls'/female caregivers home
or another private place of their choosing such as our local Johns Hopkins offices. The
program will be conducted over 2.5-3 months with one session occurring every week for 11
weeks. The total program duration is 660-990 minutes.
To adequately assess the primary research question, the investigators will enroll 60 dyads,
grouped into three cohorts of 10 dyads each, who will complete satisfaction questionnaires
after each of the program sessions and upon completion of the program. To assess preliminary
impact on girls' risk for substance use and intention about sexual activity, including
cultural connectedness, mother-daughter communication and psychological health and wellbeing,
the investigators will deliver an evaluation conducted at baseline, upon completion of the
intervention (post-intervention assessment) and 3 months following completion of the
intervention (3-month follow-up assessment). The investigators will also assess program
impact on female caregivers' substance use, parent-child communication and factors related to
the female caregivers' wellbeing through an evaluation conducted at baseline, upon completion
of the intervention (post-intervention assessment) and 3 months following completion of the
intervention (3-month follow-up assessment).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A |